Foli Bio

Long Island City, United States

Foli Bio is building a non-invasive platform to analyze gut health through stool RNA for precision medicine

$305K raised

Jul 2025

Grant

Biotechnology Health Care Health Diagnostics Precision Medicine

Top Investors

National Science Foundation Bristol-Myers Squibb Columbia Technology Ventures National Institute of Health Undisclosed Investor

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Foli Bio

How much funding has Foli Bio raised?

Foli Bio has raised $305K in total funding. The most recent round was Grant. The last funding was announced in July 2025.

Who are Foli Bio's investors?

Foli Bio's investors include National Science Foundation, Bristol-Myers Squibb, Columbia Technology Ventures, National Institute of Health, Undisclosed Investor.

Where is Foli Bio headquartered?

Foli Bio is headquartered in Long Island City, United States.

What does Foli Bio do?

Foli Bio is building a non-invasive platform to analyze gut health through stool RNA for precision medicine

What stage is Foli Bio at?

Foli Bio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 25, 2025.

MLA

"Foli Bio — Funding & Investors." VCBacked, July 25, 2025, https://www.vcbacked.co/company/foli-bio. Accessed July 2, 2026.

APA

VCBacked. (2025). Foli Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/foli-bio

Wikipedia (cite web)

{{cite web |title=Foli Bio — Funding & Investors |url=https://www.vcbacked.co/company/foli-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 25, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K